Business / Finance

RSS

China Medical Technologies second quarter net revenues increase 18.1% to RMB238.5 million

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, announced its unaudited financial results for the second fiscal quarter ended September 30, 2011 ("2Q FY2011") today.

18 Nov 2011

Sirona fourth quarter revenue increases 19.6% to $218.8 million

Sirona, the dental technology leader, today announced its financial results for the quarter and fiscal year ended September 30, 2011.

18 Nov 2011

Par Pharmaceutical acquires Anchen

Par Pharmaceutical Companies, Inc. today announced that it has completed its acquisition of Anchen Pharmaceuticals, a privately-held specialty pharmaceutical company focused on developing and commercializing extended release and niche generic products.

17 Nov 2011

Wisconsin Next Generation Jobs Act could provide funding to bioscience companies

The Wisconsin Next Generation Jobs Act, a bipartisan special legislative session bill submitted at the request of Governor Scott Walker, would provide investment capital and other types of funding to bioscience companies operating within the state.

17 Nov 2011

Kentucky Circuit Court rules in favor of Watson in drug pricing litigation

Watson Pharmaceuticals, Inc. today confirmed that a jury in the drug pricing litigation trial in the Kentucky Circuit Court for Franklin County rendered a verdict in favor of Watson on all counts in the litigation.

17 Nov 2011

MDxHealth total revenues decrease 7% for third quarter 2011

MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, today issued its business update for the third quarter and for the nine months ended September 30, 2011.

17 Nov 2011

Cigna prices public offering of 15.2 million shares of common stock

Cigna Corporation announced today that it has priced a public offering of 15.2 million shares of its common stock at $42.75 per share.

17 Nov 2011

Boehringer Ingelheim bolsters drug discovery, development with $350M in capital investments

Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.

16 Nov 2011

Pacira prices public offering of 7,000,000 shares of common stock

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its public offering of 7,000,000 shares of its common stock at a price of $6.50 per share.

16 Nov 2011

Derycz Scientific first quarter total revenue increases 64% to $9.9 million

Derycz Scientific, Inc., a leader in information logistics solutions and a pioneer in facilitating the flow of information from content publishers to enterprise customers in Life Sciences and other research intensive industries, today reported financial and operating results for the first quarter of its fiscal year 2012.

15 Nov 2011

Covidien fourth quarter net sales increase 15% to $3.08 billion

Covidien plc today reported results for the fourth quarter of fiscal 2011.

15 Nov 2011

InVivo Therapeutics reports net income of $3,067,000 for third quarter 2011

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.

15 Nov 2011

HemaCare reports third quarter revenue of $4.0M from continuing operations

HemaCare Corporation announced today that the Company generated 2011 third quarter revenue of $4.0 million from continuing operations and net income of $512,000 or $0.05/share, including net income from discontinued operations of $1,090,000.

14 Nov 2011

Cadence proposes $75M underwritten public offering of common stock

Cadence Pharmaceuticals, Inc. today announced its intention to offer and sell $75 million worth of shares of its common stock in an underwritten public offering.

14 Nov 2011

Bond Labs third fiscal quarter revenue increases 58%

Bond Laboratories, Inc., a national provider of innovative and proprietary nutritional supplements for health conscious consumers, today announced continued significant revenue growth and positive net income for the third fiscal quarter of 2011.

14 Nov 2011

Cyanotech second quarter revenues increase to $5,989,000

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal year 2012, ended September 30, 2011.

14 Nov 2011

Corgenix first quarter total revenues increase 10.1% to $2.18 million

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its fiscal quarter Form 10-Q and reported financial results.

14 Nov 2011

ABMC third quarter net sales decrease 6.5% to $2,365,000

American Bio Medica Corporation today announced financial results for the three and nine months ended September 30, 2011.

14 Nov 2011

Bovie Medical third quarter revenues decrease marginally to $6.3 million

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the third quarter and nine months ended September 30, 2011.

14 Nov 2011